Zevra Therapeutics, Inc. ZVRA
$12.63
▼ -2.47% 24H
About
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on treatments for rare diseases. The company concentrates on rare neurological and sleep-related conditions, including certain urea cycle disorders, Niemann-Pick disease type C, and idiopathic hypersomnia. Zevra Therapeutics develops and c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees61
TickerZVRA
Statistics
Market Cap$746.3M
Revenue (TTM)$106.5M
Net Income$83.2M
Net Margin78.2%
EPS$1.35
P/E6.72
P/S6.53
P/B3.88
EV/EBITDA47.01
ROE100.7%
Dividend Yield—
Price$12.63
Data: Twelve Data · Revenue = mcap / P/S